close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

319.82 -3.58 (-1.11%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Insulet Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Gapping S&P500 stocks in Thursday's session
Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Thursday. Stay informed about the latest market trends. 
Via Chartmill
Insulet Rises As Broad Omnipod Growth Stokes Beat-And-Raise Quarter
Insulet stock rose moderately early Thursday as its insulin pump, Omnipod, delivered double-digit growth in the U.S. and abroad. 
Via Investor's Business Daily
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers. 
Via Chartmill
Insulet’s (NASDAQ:PODD) Q3: Strong Sales
Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 29.9% year on year to $706.3 million. On top of that, next... 
Via StockStory
Earnings Scheduled For November 6, 2025
 
Via Benzinga
Price Over Earnings Overview: Insulet
 
Via Benzinga
Examining the Future: Insulet's Earnings Outlook
 
Via Benzinga
Insulet, Uber And A Financial Stock On CNBC's 'Final Trades'
Joseph Terranova of Virtus Investment Partners named Insulet Corp., a maker of wearable devices for insulin management, as his final trade. 
Via Benzinga
Earnings To Watch: Insulet (PODD) Reports Q3 Results Tomorrow
Insulin delivery company Insulet Corporation (NASDAQ:PODD) will be reporting results this Thursday before market hours. Here’s what investors should know. 
Via StockStory
Peering Into Insulet Corp's Recent Short Interest
 
Via Benzinga
$100 Invested In Insulet 15 Years Ago Would Be Worth This Much Today
 
Via Benzinga
INSULET CORP (NASDAQ:PODD) Demonstrates Strong Growth and Technical Momentum
Discover Insulet (PODD), a top growth stock with strong financials and a positive technical setup, making it a compelling pick for investors. 
Via Chartmill
1 Safe-and-Steady Stock to Own for Decades and 2 We Brush Off
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
Via StockStory
INSULET CORP (NASDAQ:PODD): A Prime Candidate for Affordable Growth Investing
Insulet (PODD) is a GARP stock with strong revenue & earnings growth, solid profitability, and a reasonable valuation relative to its industry peers. 
Via Chartmill
Here's How Much You Would Have Made Owning Insulet Stock In The Last 10 Years
 
Via Benzinga
Louis Navellier's Growth Strategy Highlights Insulet Corp (NASDAQ:PODD)
Discover how Louis Navellier's growth stock strategy identified Insulet Corp (PODD), a leader in innovative insulin delivery with strong earnings and sales growth. 
Via Chartmill
Discover which S&P500 stocks are making waves on Thursday.
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday. 
Via Chartmill
What's going on in today's session: S&P500 gap up and gap down stocks
Let's have a look at the S&P500 gap up and gap down stocks in today's session. 
Via Chartmill
Here's How Much $100 Invested In Insulet 15 Years Ago Would Be Worth Today
Insulet (NASDAQ: PODD) has outperformed the market over the past 15 years by 10.02% on an annualized basis producing an average annual return of 22.35%. Currently, Insulet has a market capitalization... 
Via Benzinga
A Glimpse Into The Expert Outlook On Insulet Through 6 Analysts
6 analysts have shared their evaluations of Insulet (NASDAQ: PODD) during the recent three months, expressing a mix of bullish and bearish perspectives. 
Via Benzinga
Insulet Corp (NASDAQ:PODD): An Affordable Growth Stock with Strong Profitability
Insulet Corp (PODD) exemplifies affordable growth with strong revenue & EPS expansion, high profitability, and a valuation justified by its industry-leading potential. 
Via Chartmill
Align Technology, ResMed, Insulet, Envista, and Dentsply Sirona Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential... 
Via StockStory
Topics World Trade
Here's How Much $100 Invested In Insulet 10 Years Ago Would Be Worth Today
 
Via Benzinga
Why Insulet (PODD) Shares Are Falling Today
Shares of insulin delivery company Insulet Corporation (NASDAQ:PODD) fell 4.3% in the morning session after the company announced a change in its chief financial officer, a move that appeared to... 
Via StockStory
Topics Economy
Tech Stocks Slip, Small Caps Soar Ahead Of Fed Rate Decision: What's Moving Markets Wednesday?
Small-cap and blue-chip stocks advanced in Wednesday morning trading on Wall Street, while technology names lagged and the S&P 500 hovered near record levels as investors braced for the Federal... 
Via Benzinga
Topics Economy
Top S&P500 movers in Wednesday's session
Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
Gapping S&P500 stocks in Wednesday's session
Let's have a look at the S&P500 gap up and gap down stocks in today's session. 
Via Chartmill
3 Reasons Investors Love Insulet (PODD)
Insulet has had an impressive run over the past six months as its shares have beaten the S&P 500 by 18%. The stock now trades at $337, marking a 35.7% gain. This was partly thanks to its solid... 
Via StockStory
Topics Stocks
ResMed, Insulet, Lantheus, Inspire Medical Systems, and Evolent Health Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading. 
Via StockStory
Topics Economy
Which S&P500 stocks are moving on Wednesday?
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Wednesday. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today